发明名称 HLA-A* 3303-restricted WT1 peptide and pharmaceutical composition comprising the same
摘要 Disclosed are: a peptide comprising an amino acid sequence composed of contiguous nine amino acid residues derived from a WT1 protein, wherein an amino acid residue at position 2 in the amino acid sequence is selected from the group consisting of Ala, Ile, Leu, Val, Phe, Tyr, Ser and Asp and an amino acid residue at position 9 in the amino acid sequence is Arg; a polynucleotide encoding the peptide; a pharmaceutical composition comprising the peptide; and a method for the induction of a WT1-specific CTL using the peptide.
申请公布号 US8759483(B2) 申请公布日期 2014.06.24
申请号 US200712280268 申请日期 2007.02.21
申请人 International Institute of Cancer Immunology, Inc. 发明人 Sugiyama Haruo
分类号 A61K39/00;C07K7/06 主分类号 A61K39/00
代理机构 Finnegan, Henderson, Farabow, Garrett & Dunner LLP 代理人 Finnegan, Henderson, Farabow, Garrett & Dunner LLP
主权项 1. An isolated peptide consisting of 9 contiguous amino acids from a WT1 protein, wherein the 9 contiguous amino acid sequence is Ser Asp Gln Leu Lys Arg His Gln Arg (SEQ ID No: 4).
地址 Osaka JP